| scholarly article | Q13442814 |
| P50 | author | Joseph E. Schwartz | Q56810690 |
| Vijay K Sharma | Q56952884 | ||
| P2093 | author name string | John Lee | |
| David Epstein | |||
| Sean Campbell | |||
| Surya V Seshan | |||
| Thangamani Muthukumar | |||
| Manikkam Suthanthiran | |||
| Sandip Kapur | |||
| Darshana Dadhania | |||
| Meredith Aull | |||
| Rex Friedlander | |||
| Dinesh Kannabhiran | |||
| P2860 | cites work | Using real data for a virtual crossmatch | Q33467644 |
| Clinical outcomes among renal transplant recipients with pre-transplant weakly reactive donor-specific antibodies | Q34080938 | ||
| Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation | Q34124202 | ||
| Intermediate-term graft loss after renal transplantation is associated with both donor-specific antibody and acute rejection | Q38193298 | ||
| Incidence and impact of de novo donor-specific alloantibody in primary renal allografts | Q39472834 | ||
| Flow cytometric detection of HLA antibodies using a spectrum of microbeads | Q40907524 | ||
| Organ procurement and transplantation network/united network for organ sharing histocompatibility committee collaborative study to evaluate prediction of crossmatch results in highly sensitized patients | Q42615790 | ||
| HLA-DQ barrier: effects on cPRA calculations | Q42616357 | ||
| Pre-transplant donor specific anti-HLA antibody is associated with antibody-mediated rejection, progressive graft dysfunction and patient death | Q43829027 | ||
| Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. | Q44092564 | ||
| Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification | Q44919347 | ||
| Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation | Q45627897 | ||
| Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. | Q46060462 | ||
| Complement-binding anti-HLA antibodies and kidney-allograft survival | Q46141053 | ||
| Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation | Q46270876 | ||
| Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant? | Q46630985 | ||
| Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. | Q47726666 | ||
| On the detection of anti-HLA antibodies using single antigen bead Luminex assay: lot-to-lot variations in MFI. | Q47745531 | ||
| Significance of the positive crossmatch test in kidney transplantation | Q47800073 | ||
| Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. | Q48005087 | ||
| Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. | Q50618048 | ||
| Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation. | Q50946246 | ||
| 14th International HLA and Immunogenetics Workshop Prospective Chronic Rejection Project: a three-year follow-up analysis. | Q53211821 | ||
| Application of Prastat ELISA in the determination of anti-HLA specificity for immunized patients awaiting kidney transplant: five years' experience | Q57011400 | ||
| No Association of Kidney Graft Loss With Human Leukocyte Antigen Antibodies Detected Exclusively by Sensitive Luminex Single-Antigen Testing: A Collaborative Transplant Study Report | Q59305666 | ||
| Pretransplant Donor-Specific HLA Class-I and -II Antibodies Are Associated With an Increased Risk for Kidney Graft Failure | Q60182181 | ||
| Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients | Q81137752 | ||
| C1q-Fixing Human Leukocyte Antigen Antibodies Are Specific for Predicting Transplant Glomerulopathy and Late Graft Failure After Kidney Transplantation | Q82659907 | ||
| Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes | Q83366581 | ||
| Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation | Q83401607 | ||
| Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation | Q84654882 | ||
| Outcome of kidney transplantations performed with preformed donor-specific antibodies of unknown etiology | Q86716886 | ||
| Graft failure due to noncompliance among 628 kidney transplant recipients with long-term follow-up: a single-center observational study | Q87134255 | ||
| Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies | Q87976540 | ||
| De novo donor-specific human leukocyte antigen antibodies early after kidney transplantation | Q87987780 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1156-1164 | |
| P577 | publication date | 2015-06-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Characteristics of Circulating Donor Human Leukocyte Antigen-specific Immunoglobulin G Antibodies Predictive of Acute Antibody-mediated Rejection and Kidney Allograft Failure | |
| P478 | volume | 99 |
| Q64083486 | A novel approach reveals that HLA class 1 single antigen bead-signatures provide a means of high-accuracy pre-transplant risk assessment of acute cellular rejection in renal transplantation |
| Q39105369 | Acute antibody-mediated rejection in kidney transplant recipients |
| Q51087941 | Characteristics of donor-specific anti-HLA antibodies and outcome in renal transplant patients treated with a standardized induction regimen. |
| Q92712461 | Characterization of the C1q-Binding Ability and the IgG1-4 Subclass Profile of Preformed Anti-HLA Antibodies by Solid-Phase Assays |
| Q91100165 | Class I and II human leukocyte antibodies in pediatric haploidentical allograft candidates: prevalence and risk factors |
| Q90428801 | Class and Kinetics of Weakly Reactive Pretransplant Donor-specific HLA Antibodies Predict Rejection in Kidney Transplant Recipients |
| Q39015291 | Clinical and immunological relevance of antibodies in solid organ transplantation |
| Q48255248 | Determining donor-specific antibody C1q-binding ability improves the prediction of antibody-mediated rejection in human leucocyte antigen-incompatible kidney transplantation |
| Q52605034 | Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after heart transplantation. |
| Q37097768 | Early and Sustained Reduction in Donor-Specific Antibodies in Desensitized Living Donor Kidney Transplant Recipients: A 3-Year Prospective Study |
| Q49644436 | Graft immunologic events in deceased donor kidney transplant recipients with preformed HLA-donor specific antibodies |
| Q36007256 | Interpreting Anti-HLA Antibody Testing Data: A Practical Guide for Physicians |
| Q58559130 | Long-Term Outcomes of Eculizumab-Treated Positive Crossmatch Recipients: Allograft Survival, Histologic Findings, and Natural History of the Donor-Specific Antibodies |
| Q64899061 | Preformed Donor-specific Antibodies Against HLA Class II and Graft Outcomes in Deceased-donor Kidney Transplantation. |
| Q40636545 | Prevalence and Clinical Impact of Donor-Specific Alloantibody Among Intestinal Transplant Recipients |
Search more.